Recombinant Human Inward rectifier potassium channel 16 (KCNJ16)

Shipped with Ice Packs
In Stock

Description

Functional Roles in Physiology

KCNJ16 regulates basolateral K⁺ recycling in renal tubules, maintaining Na⁺ reabsorption and acid-base balance. Key roles include:

Physiological RoleMechanismAssociated Pathway
Renal electrolyte homeostasisCouples with Kir4.1 to drive Na⁺-K⁺-ATPase activity in distal nephrons RAAS activation, NCC regulation
pH sensingModulates channel activity via intracellular pH changes Bicarbonate reabsorption
NeuromodulationStabilizes membrane potential in astrocytes and respiratory neurons Seizure suppression, CO₂ chemosensing

Loss-of-function mutations cause hypokalemia, metabolic acidosis/alkalosis, and sensorineural deafness .

Research Applications

Recombinant KCNJ16 is pivotal in modeling diseases and screening therapies:

Table 1: Key Research Models and Findings

ModelFindingsSource
KCNJ16−/− kidney organoidsLipid accumulation, TCA cycle defects, fibrosis; rescued by statins Schindler et al. 2023
Xenopus oocyte electrophysiologyImpaired K⁺ currents with KCNJ16 mutants (e.g., p.Arg65Trp) Schlingmann et al. 2021
Dahl SS Kcnj16−/− ratsSalt-sensitive hypertension, audiogenic seizures Palygin et al. 2017

Genetic Mutations

Biallelic KCNJ16 variants (e.g., p.Arg65Trp, p.Leu68Pro) are linked to:

  • Hypokalemic tubulopathy: Renal salt wasting, polyuria, RAAS activation .

  • Metabolic acidosis/alkalosis: Depends on mutant effects on Kir4.1 vs. Kir4.2 .

  • Sensorineural deafness: Moderate high-frequency hearing loss .

Therapeutic Insights

  • Statins (e.g., simvastatin + C75) reduce lipid accumulation in KCNJ16−/− organoids .

  • Pharmacological Kir5.1 activators remain under development .

Unresolved Questions and Future Directions

  1. Neurological Impact: Role in epilepsy and respiratory chemoreception requires further exploration .

  2. Cancer Links: KCNJ16 is dysregulated in T-cell lymphoma, but mechanisms are unclear .

  3. Pharmacology: Development of Kir5.1-specific modulators for acidosis/seizure disorders .

Product Specs

Buffer
For liquid delivery forms, the default storage buffer is Tris/PBS-based buffer containing 5%-50% glycerol. In the case of lyophilized powder, the buffer used prior to lyophilization is Tris/PBS-based buffer with 6% Trehalose.
Form
Liquid or Lyophilized powder
Note: We prioritize shipping the format currently in stock. However, if you have specific format preferences, please specify your requirements in the order remarks. We will accommodate your request if possible.
Lead Time
Delivery times may vary depending on the purchase method and location. Please consult your local distributors for specific delivery information.
Notes
Repeated freezing and thawing is not recommended. For optimal use, store working aliquots at 4°C for up to one week.
Reconstitution
Prior to opening, we recommend briefly centrifuging the vial to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We suggest adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%. Customers can use this as a reference.
Shelf Life
Shelf life is influenced by various factors including storage conditions, buffer components, storage temperature, and the protein's inherent stability. Generally, liquid forms have a shelf life of 6 months at -20°C/-80°C. Lyophilized forms typically have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. For multiple use, aliquoting is necessary. Avoid repeated freeze-thaw cycles.
Tag Info
N-terminal 10xHis-tagged
Datasheet & Coa
Please contact us to get it.
Expression Region
1-418aa
Mol. Weight
50.8 kDa
Protein Length
Full Length
Purity
Greater than 85% as determined by SDS-PAGE.
Research Area
Others
Source
in vitro E.coli expression system
Species
Homo sapiens (Human)
Target Names
KCNJ16
Target Protein Sequence
MSYYGSSYHIINADAKYPGYPPEHIIAEKRRARRRLLHKDGSCNVYFKHIFGEWGSYVVDIFTTLVDTKWRHMFVIFSLSYILSWLIFGSVFWLIAFHHGDLLNDPDITPCVDNVHSFTGAFLFSLETQTTIGYGYRCVTEECSVAVLMVILQSILSCIINTFIIGAALAKMATARKRAQTIRFSYFALIGMRDGKLCLMWRIGDFRPNHVVEGTVRAQLLRYTEDSEGRMTMAFKDLKLVNDQIILVTPVTIVHEIDHESPLYALDRKAVAKDNFEILVTFIYTGDSTGTSHQSRSSYVPREILWGHRFNDVLEVKRKYYKVNCLQFEGSVEVYAPFCSAKQLDWKDQQLHIEKAPPVRESCTSDTKARRRSFSAVAIVSSCENPEETTTSATHEYRETPYQKALLTLNRISVESQM
Note: The complete sequence including tag sequence, target protein sequence and linker sequence could be provided upon request.
Uniprot No.

Target Background

Function
Inward rectifier potassium channels are distinguished by their greater tendency to facilitate potassium influx into the cell rather than efflux. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium levels increase, the voltage range required for channel opening shifts to more positive values. Inward rectification is primarily attributed to the blockage of outward current by intracellular magnesium. KCNJ16 may play a role in regulating fluid and pH balance. In the kidney, along with KCNJ10, it mediates basolateral K(+) recycling in distal tubules, a process essential for Na(+) reabsorption within these tubules.
Gene References Into Functions
  1. HNF1beta acts as a transcriptional activator of Kcnj16. Consequently, patients with HNF1beta mutations may exhibit reduced Kir5.1 activity in the kidney, leading to hypokalemia and hypomagnesemia. PMID: 28577853
  2. Gene expression levels of three randomly selected differentially expressed genes (DEGs), VCAN, COL5A1 and KCNJ16, were investigated using RT-PCR in 10 ATC samples.. angiogenesis was activated by the high expression of CTHRC1, VCAN and POSTN, providing necessary nutrition for tumor cells PMID: 27599582
  3. Five de novo mutations were identified in four genes (SCNN1A, KCNJ16, KCNB2, and KCNT1) in three Brugada syndrome patients PMID: 25339316
Database Links

HGNC: 6262

OMIM: 605722

KEGG: hsa:3773

STRING: 9606.ENSP00000283936

UniGene: Hs.463985

Protein Families
Inward rectifier-type potassium channel (TC 1.A.2.1) family, KCNJ16 subfamily
Subcellular Location
Membrane; Multi-pass membrane protein. Basolateral cell membrane.
Tissue Specificity
Widely expressed, with highest levels in adult and fetal kidney (at protein level). In the kidney, expressed in the proximal and distal convoluted tubules, but not in glomeruli nor collecting ducts.

Q&A

What is the KCNJ16 gene and what does it encode?

The KCNJ16 gene encodes the inwardly rectifying potassium channel Kir5.1, which belongs to the broader family of inwardly rectifying potassium (Kir) channels. These channels are characterized by greater conductance of potassium ions into rather than out of the cell. Kir5.1 has distinctive properties among Kir channels, as it primarily forms heteromeric channels with other Kir subunits, particularly Kir4.1, rather than functioning as a homomeric channel .

What are the primary physiological functions of Kir5.1 channels?

Kir5.1 channels contribute to several critical physiological functions across multiple organ systems:

  • Renal function: Maintenance of potassium homeostasis and pH regulation in the kidney

  • Neurological function: Modulation of neuronal excitability and involvement in respiratory control

  • Auditory function: Contribution to potassium recycling in the inner ear and maintenance of the endocochlear potential

  • Acid-base balance: Regulation of pH sensing and homeostasis

Disruption of these functions through mutations or altered expression can lead to various pathologies including metabolic acidosis, hypokalemia, salt wasting, and seizure disorders .

Where is Kir5.1 primarily expressed in human tissues?

Kir5.1 shows tissue-specific expression patterns that correlate with its diverse physiological roles:

  • Kidney: Particularly in the proximal tubule where it regulates electrolyte transport

  • Brain: In various regions involved in respiratory control and other neurological functions

  • Inner ear: In structures critical for maintaining the endocochlear potential

  • Pancreas: In both exocrine and endocrine regions

  • Other tissues: Including but not limited to the respiratory system and various epithelial cells

This expression pattern highlights the multifunctional nature of this channel in human physiology .

What experimental approaches are most effective for measuring Kir5.1 channel activity?

Electrophysiological techniques remain the gold standard for functional assessment of Kir5.1 channels:

For accurate characterization, it's important to consider that Kir5.1 typically forms heteromeric channels with Kir4.1, and experimental designs should account for this co-expression requirement .

What methods are available for quantifying KCNJ16/Kir5.1 expression?

Several complementary approaches can be employed:

  • Enzyme-Linked Immunosorbent Assay (ELISA): Commercial kits are available for detecting Human Inward Rectifier Potassium Channel 16 in various sample types including serum, plasma, biological fluids, and cell culture supernatant. These assays typically utilize indirect sandwich assay methodology with capture and detection antibodies to ensure high sensitivity and specificity .

  • Quantitative PCR (qPCR): For mRNA quantification, which has been widely used in studies examining differential expression in various disease states.

  • Western blot analysis: For protein level quantification, though specificity of antibodies should be carefully validated.

  • RNA sequencing: For transcriptomic analysis, which has been employed to identify KCNJ16 as a differentially expressed gene in various conditions .

What animal models are available for studying KCNJ16 function and pathology?

Several animal models have been developed that are valuable for investigating Kir5.1 function:

  • Knockout mouse models: These have revealed phenotypes including pH and electrolyte imbalances, blunted ventilatory responses to hypercapnia/hypoxia, and seizure disorders .

  • Rat models with Kcnj16 mutations: Including specific mutations such as the I26T variant generated in Dahl salt-sensitive rats using CRISPR-based approaches. These models allow investigation of the channel's role in salt-sensitive hypertension, electrolyte homeostasis, and kidney function .

  • Disease-specific models: Animals designed to recapitulate specific human conditions associated with KCNJ16 mutations.

When using these models, researchers should consider species-specific differences in channel properties and expression patterns .

What human disorders have been linked to KCNJ16 mutations?

Several clinical conditions have been associated with mutations in the KCNJ16 gene:

  • Hypokalemia with renal salt wasting: Characterized by low serum potassium levels and salt loss through the kidneys.

  • Disturbed acid-base homeostasis: Particularly metabolic acidosis with low serum bicarbonate levels.

  • Sensorineural deafness: Hearing loss resulting from damage to the inner ear structures.

  • Developmental delay: Observed in some patients with KCNJ16 mutations.

  • Seizure disorders: Including various forms of epilepsy.

  • Potential involvement in Brugada syndrome: KCNJ16 has been identified as one of the mutated genes in patients with non-familial Brugada syndrome lacking SCN5A variants .

How do different types of KCNJ16 mutations affect channel function and disease presentation?

The relationship between mutation type and phenotype is complex:

  • Missense mutations: These account for approximately 77.8% of identified pathogenic variants. The specific location and nature of the amino acid substitution significantly influence the resulting phenotype.

  • Nonsense mutations: These truncating mutations account for about 22.2% of pathogenic variants and often result in more severe phenotypes due to complete loss of function.

  • Location-specific effects: The position of the mutation within the channel protein is critical. For example, the I26T variant (located at the N-terminus) appears to be a benign population-specific variant without associated pathology, despite initial suspicion .

This highlights the importance of considering both mutation type and location when diagnosing and treating patients with KCNJ16 mutations .

What is the evidence linking KCNJ16 mutations to respiratory control disorders?

Research has revealed important connections between Kir5.1 function and respiratory control:

  • Animal studies have shown that Kir5.1 knockout reduces respiratory compensatory responses to hypercapnia (elevated CO2) and hypoxia (low oxygen).

  • The mechanism may involve abnormal signal transmission between peripheral respiratory chemoreceptors and central respiratory chemoreceptors, or disorders in signal reception by central chemoreceptors.

  • A specific KCNJ16 R137S mutant has been identified that may cause disorders in signal reception in central respiratory chemoreceptors, potentially representing a risk factor for Sudden Infant Death Syndrome (SIDS) .

Additionally, metabolic acidosis caused by proximal tubular dysfunction in Kir5.1 knockout models may impact respiratory chemoreceptor function, creating a complex interrelationship between renal and respiratory phenotypes .

How is KCNJ16 expression altered in different cancer types?

KCNJ16 shows cancer-specific expression patterns that may have diagnostic and prognostic significance:

Cancer TypeKCNJ16 ExpressionPotential Clinical Significance
Anaplastic thyroid carcinoma (ATC)DownregulatedAssociated with tumor progression
Pancreatic ductal adenocarcinoma (PDAC)DownregulatedPotential diagnostic marker
Clear cell renal cell carcinoma (ccRCC)DownregulatedRelated to transmembrane transport and cell structure maintenance
Parathyroid carcinoma (PCA)UpregulatedPotential diagnostic marker
Prostate cancerUpregulatedAssociated with Gleason score and biochemical recurrence risk
Hepatocellular carcinoma (HCC)UpregulatedUseful for early diagnosis

These expression patterns suggest that KCNJ16 may serve as either a tumor suppressor or oncogene depending on the specific cancer context .

What methodological approaches are recommended for studying KCNJ16 in cancer research?

Researchers investigating KCNJ16 in cancer contexts should consider a multi-faceted approach:

  • Transcriptomic analysis: RNA sequencing or microarray analysis to identify differential expression between tumor and normal tissues.

  • RT-qPCR validation: To confirm expression changes in cell lines and patient samples.

  • Functional studies: To determine the consequences of altered KCNJ16 expression on cancer cell proliferation, migration, and invasion.

  • Clinical correlation: Analysis of the relationship between KCNJ16 expression and clinical parameters such as tumor stage, grade, and patient outcome.

  • Mechanistic investigations: To understand how altered potassium channel function contributes to cancer pathophysiology.

The specific methodology should be tailored to the cancer type being studied, as KCNJ16 appears to play distinct roles in different malignancies .

What are the current challenges in developing selective modulators of Kir5.1 channels?

Several factors complicate the development of Kir5.1-specific modulators:

  • Heteromeric assembly: Kir5.1 predominantly forms heteromeric channels with Kir4.1, making it challenging to target Kir5.1 specifically without affecting other channel combinations.

  • Structural similarities: The high degree of structural homology between different Kir family members necessitates highly selective compounds to avoid off-target effects.

  • Limited structural data: Despite advances in ion channel structural biology, detailed structural information specific to Kir5.1-containing channels remains incomplete.

Future studies focusing on the development of selective small-molecule inhibitors for Kir5.1 channels will significantly advance our understanding of this unique Kir channel family member and potentially lead to therapeutic applications .

How might expanded genetic screening for KCNJ16 variants improve clinical diagnosis and treatment?

Enhanced genetic screening approaches offer several potential benefits:

  • Improved diagnosis of conditions associated with KCNJ16 mutations, particularly in cases with atypical clinical presentations.

  • Identification of novel variants and better characterization of genotype-phenotype correlations.

  • Development of personalized treatment approaches based on the specific mutation type and location.

  • Expanded understanding of the prevalence of KCNJ16 variants in different populations, as demonstrated by the discovery that the I26T variant is a population-specific benign variant in the Amish community with an allele frequency of 4.3% .

The type and location of variants should be carefully considered when diagnosing and treating patients, as evidenced by the I26T variant which, despite initial suspicion, was found to be non-pathogenic in both humans and rat models .

What unexplored physiological roles might Kir5.1 channels play beyond currently known functions?

Several intriguing areas warrant further investigation:

  • Potential roles in non-traditional tissues where expression has been detected but function remains poorly characterized.

  • Involvement in cellular responses to metabolic stress and hypoxia, given the channel's pH sensitivity.

  • Possible contributions to circadian rhythm regulation and sleep physiology, which may connect to the observed respiratory phenotypes.

  • Unexplored interactions with other ion channels and transporters that may reveal novel regulatory mechanisms.

  • Potential developmental roles, suggested by the observation of developmental delays in some patients with KCNJ16 mutations .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.